Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 803 results for "iibs"

EBS, REGN Get FDA Nod, OVAS To Deliver, Recro Recuperates, Watch Out For ZSAN
RTTNews.com

EBS, REGN Get FDA Nod, OVAS To Deliver, Recro Recuperates, Wat...

Dermira Inc. (DERM: Quote), which recently announced positive results from a phase 2a clinical trial for DRM01 in patients with acne, expects to start a phase 2b trial in April 2015. The company also intends to commence its phase 3 program in ... RTTNews.com, 4 days ago

73 images for iibs

Pharma Letter, 5 days ago
GlobeNewswire, 4 days ago
Pharma Letter, 1 week ago
DePauw University, 6 days ago
Nasdaq, 6 days ago
DePauw University, 1 week ago
Guam Pacific Daily News, 2 weeks ago
Healthista, 1 week ago
The Express Tribune, 2 weeks ago
KXXV-TV, 2 weeks ago

Teva's Phase IIb episodic migraine study meets primary and secondary endpoints

Teva Pharmaceutical Industries Ltd., a manufacturer of generic pharmaceuticals, has announced that TEV-48125 met its primary and secondary endpoints in a Phase IIb study in patients with episodic migraine. The company also announced the successful ...
 Individual.com4 days ago Teva Migraine Drug Scores In Race With Alder, Lilly  Investor's Business Daily6 days ago Teva's TEV-48125 Meets Primary and Secondary Endpoints in Episodic Migraine Study, Demonstrating Treatment Concept After a Single Dose  Pettinga Financial Advisors6 days ago Teva: TEV-48125 Meets Primary and Secondary Endpoints in Episodic Migraine Study [Health & Beauty Close - Up]  Pharmacy Choice3 days ago
[x]  
SCL.org

Dr Download: Apps and Wearables as Medical Devices

Neil Brown and Sandra Brown offer an introduction to the regulation of apps and wearables as medical devices Phones are increasingly equipped with a range of devices capable of being used as sensors, including gyroscopes, accelerometers, ...
 SCL.org3 days ago

DaVita Clinical Research to Present Clinical Quality Results at the National Kidney Foundation Spring Clinical Meeting

DaVita Kidney Care, the kidney care division of DaVita HealthCare Partners Inc., and DCR are committed to improving patient care and experience through real-world pilots that may enhance clinical outcomes. The results shared by DaVita Kidney Care ...
 Wall Street Select4 days ago
[x]  

Nocturia Therapeutic Pipeline Key Players and Drugs Review H1 2015 Market Research Report

/PRNewswire/ -- RnRMarketResearch.com adds "Nocturia - Pipeline Review, H1 2015" therapeutic market research report provides an overview of the Nocturia's therapeutic pipeline. The report " Nocturia - Pipeline Review, H1 2015 " provides ...
 CEOWorld Magazine4 days ago
[x]  

Novasep, Celladon sign agreement to develop and supply MYDICAR drug substance

Novasep, a leading supplier of services and technologies for the life sciences and chemical industries, and Celladon Corporation (Nasdaq:CLDN), a clinical-stage cardiovascular gene therapy company, today announce that they have signed a Development, ...
 News-Medical.Net3 days ago Novasep and Celladon Execute MYDICAR API Supply Agreement  BioSpace5 days ago Novasep And Celladon Corporation Execute MYDICAR API Supply Agreement  BioSpace4 days ago
[x]  

Cellular Biomedicine Group (CBMG) Announces Interim Results From Phase IIb Clinical Trial For Knee Osteoarthritis Stem Cell Rejoin Therapy 3/25/2015

(GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (Nasdaq:CBMG) ("CBMG" or the "Company"), a biomedicine firm engaged in the development of effective treatments for degenerative and cancerous diseases, today announced interim 24-week clinical data ...
 ClinicSpace4 days ago Cellular Biomedicine Group Announces Interim Results From Phase IIb Clinical Trial for Knee Osteoarthritis Stem Cell ReJoin(TM) Therapy  Market Pulse Navigator4 days ago CELLULAR BIOMEDICINE : to Present Osteoarthritis Stem Cell Rejoin(TM) Therapy and Cancer CAR-T Therapy Clinical Development Programs at the 2015...  4 Traders1 week ago Cellular Biomedicine Group to Present Osteoarthritis Stem Cell Rejoin(TM) Therapy and Cancer CAR-T Therapy Clinical Development Programs at the 2015 Annual Regen Med Investor Day  CNN Money1 week ago
[x]  

Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with...

Data from Evidence of Effect Trial Provide Supportfor Novel Mechanism of Action in Neuromuscular Diseases South San Francisco, CA, March 25, 2015 - Cytokinetics, Incorporated (Nasdaq: CYTK) announced the publication of a manuscript relating to ...
 Stockhouse Canada4 days ago Cytokinetics : Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis  4 Traders4 days ago
[x]  

Research and Markets Adds Report: Galapagos's Filgotinib Rheumatoid Arthritis Report - Forecast and Market Analysis to 2023

Research and Markets has announced the addition of the "Filgotinib (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023" report to its offerings. In a release, Research and Markets noted that report highlights include: Rheumatoid ...
 Individual.com4 days ago Clazakizumab (Rheumatoid Arthritis) Market Study Report - Forecast and Market Analysis to 2023  Digital Journal4 days ago MedImmune's Mavrilimumab (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023  Individual.com5 days ago Galapagos's Filgotinib Rheumatoid Arthritis Report - Forecast and Market Analysis to 2023  Individual.com6 days ago
[x]  

Lightning Rod: F-35 Fighter Family Capabilities and Controversies

Grim Reapers F-35C (click to view full) The $400 billion F-35 Joint Strike fighter program may well be the largest single global defense program in history. This major multinational program is intended to produce an affordably stealthy ...
 Defense Industry Daily4 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less